YU75093A - Transdermalni sistem za davanje koji sadrži acetilsalicilnu kiselinu za antitromboznu terapiju i profilaksu raka - Google Patents

Transdermalni sistem za davanje koji sadrži acetilsalicilnu kiselinu za antitromboznu terapiju i profilaksu raka

Info

Publication number
YU75093A
YU75093A YU75093A YU75093A YU75093A YU 75093 A YU75093 A YU 75093A YU 75093 A YU75093 A YU 75093A YU 75093 A YU75093 A YU 75093A YU 75093 A YU75093 A YU 75093A
Authority
YU
Yugoslavia
Prior art keywords
therapy
acetylsalicylic acid
prophylax
thrombose
cancer
Prior art date
Application number
YU75093A
Other languages
English (en)
Inventor
F. Becher
Original Assignee
Lts Lohmann Therapie - Sisteme Gmbh. And Co. Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie - Sisteme Gmbh. And Co. Kg. filed Critical Lts Lohmann Therapie - Sisteme Gmbh. And Co. Kg.
Publication of YU75093A publication Critical patent/YU75093A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

TRANSDERMALNI SISTEM ZA DAVANJE KOJI SADRŽI ACETILSALICILNU KISELINU ZA ANTITROMBOZNU TERAPIJU I PROFILAKSU RAKA se odnosi na transdermalni sistem za davanje za antitromboznu terapiju, odnosno za profilaksu protiv raka, koji kao aktivnu materiju sadrži acetilsalicilnu kiselinu i/ili farmaceutski prihvatijive soli iste.
YU75093A 1991-12-20 1993-12-02 Transdermalni sistem za davanje koji sadrži acetilsalicilnu kiselinu za antitromboznu terapiju i profilaksu raka YU75093A (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4142483 1991-12-20
DE4241128A DE4241128C2 (de) 1991-12-20 1992-12-07 Verwendung eines transdermalen Verabreichungssystems, das als Wirkstoff Acetylsalicylsäure und/oder pharmazeutisch akzeptable Salze davon enthält

Publications (1)

Publication Number Publication Date
YU75093A true YU75093A (sh) 1997-08-22

Family

ID=6447817

Family Applications (1)

Application Number Title Priority Date Filing Date
YU75093A YU75093A (sh) 1991-12-20 1993-12-02 Transdermalni sistem za davanje koji sadrži acetilsalicilnu kiselinu za antitromboznu terapiju i profilaksu raka

Country Status (23)

Country Link
US (2) US6264978B1 (sh)
EP (1) EP0617623B1 (sh)
JP (1) JP3748270B2 (sh)
KR (2) KR100267442B1 (sh)
AT (1) ATE217528T1 (sh)
AU (1) AU667067B2 (sh)
CA (1) CA2125662C (sh)
CZ (1) CZ285190B6 (sh)
DE (2) DE4241128C2 (sh)
DK (1) DK0617623T3 (sh)
ES (1) ES2176197T3 (sh)
FI (1) FI113838B (sh)
HR (1) HRP921157A2 (sh)
HU (1) HU221679B1 (sh)
IL (1) IL103917A (sh)
NO (1) NO306599B1 (sh)
NZ (1) NZ246158A (sh)
PT (1) PT617623E (sh)
SI (1) SI9200312A (sh)
SK (1) SK67094A3 (sh)
WO (1) WO1993012799A1 (sh)
YU (1) YU75093A (sh)
ZA (1) ZA922814B (sh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240917A (en) * 1991-04-03 1993-08-31 Keimowitz Rudolph M Suppression of thromboxane levels by percutaneous administration of aspirin
WO1994013302A1 (de) * 1991-12-20 1994-06-23 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Ein acetylsalicylsäure enthaltendes transdermales verabreichungssystem für die antithrombotische therapie und die krebsprophylaxe
US6071896A (en) * 1992-06-16 2000-06-06 Gundersen Clinic, Ltd. Suppression of thromboxane levels by percutaneous administration of aspirin
CZ149495A3 (en) * 1992-12-07 1996-03-13 Lohmann Therapie Syst Lts Transdermally administered system containing acetylsalicylic acid for antithrombotic therapy with cancer prophylaxis
DE4332093C2 (de) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung
DE4429663C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Hydrolyseschutz
AU6709096A (en) * 1995-07-27 1997-02-26 Cal International Limited Pharmaceutical preparation for percutaneous absorbtion
WO1997004757A1 (en) * 1995-07-27 1997-02-13 Cal International Limited Transdermal nitrate formulation
WO1997004759A1 (en) * 1995-07-27 1997-02-13 Cal International Limited Transdermal patch containing aspirin
DE69635298T2 (de) * 1995-12-26 2006-07-13 Teikoku Seiyaku K.K. Verwendung von Acetylsalicylsäuren zur Herstellung eines Medikaments für die Behandlung von Hautverletzungen
DE19601487C2 (de) * 1996-01-17 2001-09-13 Micronas Gmbh Vorrichtung zum Behandeln von malignen Gewebsveränderungen
JPH1112177A (ja) 1997-06-25 1999-01-19 Teikoku Seiyaku Co Ltd 安定なアスピリン含有外用製剤
DE19949252B4 (de) * 1999-10-13 2004-02-12 Lts Lohmann Therapie-Systeme Ag Verwendung eines superfiziellen therapeutischen Systems zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen und Verfahren zu seiner Herstellung
JP2001187739A (ja) * 1999-12-28 2001-07-10 Teikoku Seiyaku Co Ltd アレルギー性皮膚疾患治療用外用剤
WO2003018023A1 (en) * 2001-08-23 2003-03-06 Bruce Frome Compositions and methods for targeting cerebral circulation and treatment of headache
US20040248858A1 (en) * 2003-06-09 2004-12-09 Parghi Kaumil H. Cure for cancer
US20060127463A1 (en) * 2004-12-15 2006-06-15 Nugara Peter N Composite structure including a low vinyl acetate layer
US20060188558A1 (en) * 2005-02-18 2006-08-24 Mylan Technologies, Inc. Transdermal systems having control delivery system
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
WO2008007171A1 (en) 2006-07-09 2008-01-17 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of aspirin
JP2010526945A (ja) * 2007-05-09 2010-08-05 バックマン・ラボラトリーズ・インターナショナル・インコーポレーテッド 紙及び板紙用のａｓａサイジングエマルジョン
JP2010529101A (ja) * 2007-06-04 2010-08-26 テックフィールズ インコーポレイテッド 非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用
MX362949B (es) 2008-12-04 2019-02-27 Yu Chongxi Composiciones de alta penetracion y sus aplicaciones.
WO2011076401A1 (de) 2009-12-23 2011-06-30 Holger Schankin Acetylsalicylsäure-haltige, im wesentlichen wasserfreie pharmazeutische zusammensetzungen
CN107929743B (zh) 2012-01-18 2023-09-01 苏州泰飞尔医药有限公司 治疗肺部疾病的高穿透力前药组合物和医药组合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
FR2297612A1 (fr) 1975-01-20 1976-08-13 Moorleghem Guy Van Procede de fabrication d'un produit analgesique a usage externe
US4012508A (en) 1975-02-03 1977-03-15 Burton Verna M Topical composition and method
US4219548A (en) 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
FR2496459A1 (fr) 1980-12-19 1982-06-25 Astier Laboratoires Docteur P Composition pharmaceutique sous forme d'un gel contenant de l'acide acetylsalicylique
US4460368A (en) * 1981-10-29 1984-07-17 Almedco, Inc. Trans-dermal medication system
IL68965A (en) 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
US4640689A (en) * 1983-08-18 1987-02-03 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
DE3583698D1 (de) 1984-04-23 1991-09-12 Kao Corp Perkutaner absorptions-beschleuniger und diesen enthaltendes praeparat.
JPS61167615A (ja) 1985-01-18 1986-07-29 Teisan Seiyaku Kk 薬剤投与方法
US4810699A (en) 1987-02-20 1989-03-07 American Home Products Corporation Substituted 1,3,4,9-tetrahydropyrano[3,4,-b]indole-1-acetic acids, pharmaceutical compositions containing them, and methods for treating inflammatory conditions and for analgesic purposes using them
JPH01203336A (ja) 1988-02-09 1989-08-16 Teikoku Seiyaku Kk 経皮・口腔粘膜適用製剤
JPH01242521A (ja) 1988-03-23 1989-09-27 Nikko Kemikaruzu Kk 経皮吸収性を高めた消炎鎮痛薬組成物
US4975269A (en) 1989-07-31 1990-12-04 Leonard Chavkin Shelf stable aspirin solutions
KR100247441B1 (ko) * 1991-04-03 2000-04-01 자클린 비. 슈라고 트롬복산 레벨 억제용 경피투여 약제학적 아스피린 조성물

Also Published As

Publication number Publication date
DE4241128C2 (de) 1996-05-23
US5861170A (en) 1999-01-19
IL103917A (en) 1996-09-12
HU221679B1 (hu) 2002-12-28
SI9200312A (en) 1993-06-30
US6264978B1 (en) 2001-07-24
KR100267442B1 (ko) 2000-11-01
KR950703972A (ko) 1995-11-17
DE59209956D1 (de) 2002-06-20
NO306599B1 (no) 1999-11-29
EP0617623A1 (de) 1994-10-05
JPH07502521A (ja) 1995-03-16
ZA922814B (en) 1993-06-23
CA2125662A1 (en) 1993-07-08
HRP921157A2 (en) 1994-10-31
FI113838B (fi) 2004-06-30
JP3748270B2 (ja) 2006-02-22
HUT74559A (en) 1997-01-28
ATE217528T1 (de) 2002-06-15
DK0617623T3 (da) 2002-09-09
NZ246158A (en) 1995-10-26
CZ285190B6 (cs) 1999-06-16
FI942922A (fi) 1994-06-17
DE4241128A1 (en) 1993-06-24
HU9401849D0 (en) 1994-09-28
NO942325D0 (no) 1994-06-17
IL103917A0 (en) 1993-04-04
FI942922A0 (fi) 1994-06-17
CA2125662C (en) 2006-10-17
AU3158993A (en) 1993-07-28
PT617623E (pt) 2002-10-31
KR100267359B1 (ko) 2000-11-01
CZ145694A3 (en) 1995-01-18
EP0617623B1 (de) 2002-05-15
ES2176197T3 (es) 2002-12-01
AU667067B2 (en) 1996-03-07
WO1993012799A1 (de) 1993-07-08
SK67094A3 (en) 1995-03-08
NO942325L (no) 1994-06-17

Similar Documents

Publication Publication Date Title
YU75093A (sh) Transdermalni sistem za davanje koji sadrži acetilsalicilnu kiselinu za antitromboznu terapiju i profilaksu raka
ATE96308T1 (de) Dosierform fuer verabreichung in der humanmedizin.
GEP20063773B (en) Steroid Sulphatase Inhibitors
NO306377B1 (no) Doseform for avgivelse av et medikament
ES2067939T3 (es) Sistema de distribucion de un medicamento iontoforetico con un perfil de reparto de dos etapas.
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
IT1261849B (it) Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
IS1858B (is) Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur
NO923859L (no) Medikament
ZA866917B (en) Transdermal aqueous aryl-propionic-acid derivatives medication and methods of preparing same
ATE149496T1 (de) Derivate von nicht-steroidalen entzündungshemmenden analgetischen und/oder antipyretischen arzneimitteln, ihre verwendung und diese enthaltende pharmazeutische zubereitungen
PT1003477E (pt) Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel
CA2231176A1 (en) Long active composition for rectal administration
YU49390A (sh) Postupak za izradu transdermalnog terapijskog sistema sa stupnjevitim otpuštanjem aktivne materije
ATE170075T1 (de) Antivirales arzneimittel enthaltend prostratin
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
ITMI911950A0 (it) Sistema terapeutico transdermale per la somministrazione di farmaci ad attivita' broncodilatante
NO952234L (no) Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft
WO2001041771A3 (de) Acetylsalicylsäure enthaltendes transdermales system zur behandlung von migräne
RU95109228A (ru) Способ лечения трофических язв